General Information of Drug (ID: DMNX9FC)

Drug Name
Aminomethylcyclohexane Drug Info
Synonyms
Cyclohexanemethylamine; Cyclohexylmethanamine; 3218-02-8; Aminomethylcyclohexane; (Aminomethyl)cyclohexane; Cyclohexanemethanamine; 1-Cyclohexylmethanamine; Hexahydrobenzylamine; 1-cyclohexylmethylamine; 4-aminomethylcyclohexane; C-Cyclohexyl-methylamine; CHEMBL1049; DECARBOXYLATED DERIVATIVE; AVKNGPAMCBSNSO-UHFFFAOYSA-N; EINECS 221-741-8; NSC 172991; BRN 0635751; 1tng; Cyclohexanemethyamine; cyclohexylmethyl amine; cyclohexanemethylamirie; CyclohexYl-Methanamine; cyclohexanemethyl amine; cyclohexane methylamine
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
76688
CAS Number
CAS 3218-02-8
TTD Drug ID
DMNX9FC

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fosfomycin DMVGPMX Bacterial infection 1A00-1C4Z Approved [2]
Uridine-Diphosphate-N-Acetylglucosamine DMEQSTP Discovery agent N.A. Investigative [3]
RWJ-3981 DMBVLCQ Gram-positive bacterial infection 1B74-1G40 Investigative [4]
RWJ-140998 DMP7SI9 Gram-positive bacterial infection 1B74-1G40 Investigative [4]
EUPATORIOPICRIN DM068CY Discovery agent N.A. Investigative [5]
CNICIN DMEVM0J Discovery agent N.A. Investigative [5]
L-Iso-Aspartate DM26AB4 Discovery agent N.A. Investigative [1]
Cyclohexylammonium Ion DMYQH2N Discovery agent N.A. Investigative [1]
CYNAROPICRIN DMG0PHU Discovery agent N.A. Investigative [5]
⏷ Show the Full List of 9 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Bacterial UDP-N-acetylglucosamine carboxyvinyltransferase (Bact murA) TTICX3S MURA_ECOLI Inhibitor [1]

References

1 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
2 Evidence that the fosfomycin target Cys115 in UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) is essential for product release. J Biol Chem. 2005 Feb 4;280(5):3757-63.
3 DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41.
4 Emerging drugs for bacterial urinary tract infections. Expert Opin Emerg Drugs. 2005 May;10(2):275-98.
5 Sesquiterpene lactones are potent and irreversible inhibitors of the antibacterial target enzyme MurA. Bioorg Med Chem Lett. 2006 Nov 1;16(21):5605-9.